FTO and obesity due to melanocortin 4 receptor deficiency: Although we cannot know which phenotypic effects of IOX3 treatment are due to inhibition of FTO and which are due to inhibition of other 2OG oxygenases including the PHDs, future compounds designed to selectively inhibit FTOs demethylase activity could be therapeutically useful for the treatment of obesity.